Hendrik G. STUNNENBERG
Nijmegen Medical Centre (NL)
Professor Stunnenberg's research focuses on the regulation of gene transcription and chromatin
in normal and deregulated cells with the objective to unravel the mechanisms and transcription
factor networks as well as the role of chromatin in development differentiation and disease.
main focus is on hematopoietic cells and their malignant counterparts, and on the mechanisms
and control of pluripotency in embryonic stem cells.
He is coordinator of the EU-FP7 High Impact Project BLUEPRINT (www.blueprintepigenome.eu) that aims to further our understanding of how our genes are activated or
repressed, in particular in blood cells of both healthy and diseased individuals.
generate at least 100 reference epigenomes and study them to advance and exploit knowledge
of the underlying biological processes and mechanisms in health and disease.
He is member of
the International Scientific Steering Committee of the International Human Epigenome
He is partner in the International Cancer Genome Consortium (ICGC) and
member of the Technical Working Group for Epigenetics.
As coordinator of BLUEPRINT and core participant in many other EU-projects, he has extensive
collaborations with SMEs that are leaders in (bio)technology and pharmacology.